Cargando…

Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism

Background. Data on the relationship between homocysteine, plasminogen activator inhibitor 1, hs-CRP, fibrinogen, and carotid intima media thickness (CA-IMT) is plenty but contradicting and the majority of the studies investigated this issue in only specific thyroidism groups. The aim of this paper...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunduz, Mehmet, Gunduz, Ercan, Kircelli, Fatih, Okur, Nazan, Ozkaya, Mesut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296143/
https://www.ncbi.nlm.nih.gov/pubmed/22505888
http://dx.doi.org/10.1155/2012/109797
_version_ 1782225676462456832
author Gunduz, Mehmet
Gunduz, Ercan
Kircelli, Fatih
Okur, Nazan
Ozkaya, Mesut
author_facet Gunduz, Mehmet
Gunduz, Ercan
Kircelli, Fatih
Okur, Nazan
Ozkaya, Mesut
author_sort Gunduz, Mehmet
collection PubMed
description Background. Data on the relationship between homocysteine, plasminogen activator inhibitor 1, hs-CRP, fibrinogen, and carotid intima media thickness (CA-IMT) is plenty but contradicting and the majority of the studies investigated this issue in only specific thyroidism groups. The aim of this paper was to investigate these relations in patients with subclinical and clinical hypo- and hyperthyroidism. Methods. In this cross-sectional study, 16 patients from each thyroidism group and 20 healthy cases were enrolled. Fibrinogen levels and plasminogen activator inhibitor 1 (PAI-1) activity were assessed. CA-IMT was determined by gray-scale high-resolution color Doppler ultrasound. Results. Serum homocysteine levels were higher in hypothyroidic patients compared to the control (P = 0.003). Fibrinogen levels were higher in patients with subclinical hypothyroidism compared to other groups (P < 0.05). There was no difference between groups regarding PAI-1. Whereas total cholesterol, homocysteine, and LDL were correlated with CAIMT, hs-CRP, PAI-1, and fibrinogen were not. In the clinical hypothyroidism group, the correlation of homocysteine with CA-IMT was derived from the correlation between CA-IMT and homocysteine. Conclusions. Homocysteine and fibrinogen levels are higher in patients with clinical and subclinical hypothyroidism, respectively. Homocysteine level is associated with CA-IMTonly in patients with clinical hypothyroidism.
format Online
Article
Text
id pubmed-3296143
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32961432012-04-13 Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism Gunduz, Mehmet Gunduz, Ercan Kircelli, Fatih Okur, Nazan Ozkaya, Mesut Int J Endocrinol Clinical Study Background. Data on the relationship between homocysteine, plasminogen activator inhibitor 1, hs-CRP, fibrinogen, and carotid intima media thickness (CA-IMT) is plenty but contradicting and the majority of the studies investigated this issue in only specific thyroidism groups. The aim of this paper was to investigate these relations in patients with subclinical and clinical hypo- and hyperthyroidism. Methods. In this cross-sectional study, 16 patients from each thyroidism group and 20 healthy cases were enrolled. Fibrinogen levels and plasminogen activator inhibitor 1 (PAI-1) activity were assessed. CA-IMT was determined by gray-scale high-resolution color Doppler ultrasound. Results. Serum homocysteine levels were higher in hypothyroidic patients compared to the control (P = 0.003). Fibrinogen levels were higher in patients with subclinical hypothyroidism compared to other groups (P < 0.05). There was no difference between groups regarding PAI-1. Whereas total cholesterol, homocysteine, and LDL were correlated with CAIMT, hs-CRP, PAI-1, and fibrinogen were not. In the clinical hypothyroidism group, the correlation of homocysteine with CA-IMT was derived from the correlation between CA-IMT and homocysteine. Conclusions. Homocysteine and fibrinogen levels are higher in patients with clinical and subclinical hypothyroidism, respectively. Homocysteine level is associated with CA-IMTonly in patients with clinical hypothyroidism. Hindawi Publishing Corporation 2012 2012-02-23 /pmc/articles/PMC3296143/ /pubmed/22505888 http://dx.doi.org/10.1155/2012/109797 Text en Copyright © 2012 Mehmet Gunduz et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Gunduz, Mehmet
Gunduz, Ercan
Kircelli, Fatih
Okur, Nazan
Ozkaya, Mesut
Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
title Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
title_full Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
title_fullStr Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
title_full_unstemmed Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
title_short Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
title_sort role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296143/
https://www.ncbi.nlm.nih.gov/pubmed/22505888
http://dx.doi.org/10.1155/2012/109797
work_keys_str_mv AT gunduzmehmet roleofsurrogatemarkersofatherosclerosisinclinicalandsubclinicalthyroidism
AT gunduzercan roleofsurrogatemarkersofatherosclerosisinclinicalandsubclinicalthyroidism
AT kircellifatih roleofsurrogatemarkersofatherosclerosisinclinicalandsubclinicalthyroidism
AT okurnazan roleofsurrogatemarkersofatherosclerosisinclinicalandsubclinicalthyroidism
AT ozkayamesut roleofsurrogatemarkersofatherosclerosisinclinicalandsubclinicalthyroidism